# Complement-Mediated Hemolytic Anemia Triggered by Adenovirus Infection in a Pediatric Patient

**Authors:** Gordon Fuller, Malcolm Anderson

PMC · DOI: 10.7759/cureus.104180 · Cureus · 2026-02-24

## TL;DR

A child developed a rare form of anemia after an adenovirus infection, highlighting the importance of recognizing and treating this condition.

## Contribution

This case identifies adenovirus as a potential trigger for paroxysmal cold hemoglobinuria in children.

## Key findings

- The patient showed acute hemolytic anemia with jaundice and elevated LDH following a viral illness.
- Diagnosis was confirmed by a positive Donath-Landsteiner antibody and complement-positive DAT.
- Supportive treatment led to clinical stabilization and recovery.

## Abstract

Paroxysmal cold hemoglobinuria (PCH) is a rare form of complement-mediated hemolytic anemia in children. It is typically triggered by viral infections and mediated by Donath-Landsteiner antibodies, which induce intravascular hemolysis upon cold exposure. We reviewed the clinical course, laboratory findings, and management of a pediatric adenovirus-associated PCH to highlight diagnostic and therapeutic considerations. The eight-year-old previously healthy, unimmunized female patient presented with acute hemolytic anemia following a febrile viral illness. She developed jaundice and severe anemia with reticulocytosis, hyperbilirubinemia, and elevated lactate dehydrogenase (LDH). The direct antiglobulin test (DAT) was positive for complement (C3) but negative for immunoglobulin G (IgG). Blood bank evaluation revealed a positive Donath-Landsteiner antibody, confirming PCH. Treatment included normothermia, intravenous methylprednisolone, intravenous immunoglobulin (IVIG), epoetin alfa, folic acid, and empiric azithromycin. The patient’s clinical condition stabilized with gradual hematologic recovery and resolution of symptoms. This case identifies adenovirus as a potential trigger for PCH in children and emphasizes the importance of early recognition, laboratory confirmation, and supportive management.

## Linked entities

- **Chemicals:** methylprednisolone (PubChem CID 6741), epoetin alfa (PubChem CID 92043599), folic acid (PubChem CID 135398658), azithromycin (PubChem CID 447043)
- **Diseases:** paroxysmal cold hemoglobinuria (MONDO:0019533), hemolytic anemia (MONDO:0003664)

## Full-text entities

- **Diseases:** hemolytic anemia (MESH:D000743), hyperbilirubinemia (MESH:D006932), anemia (MESH:D000740), PCH (MESH:D006457), reticulocytosis (MESH:D045262), febrile viral illness (MESH:D014777), Adenovirus Infection (MESH:D000257), intravascular hemolysis (MESH:D006461), jaundice (MESH:D007565), Complement-Mediated Hemolytic Anemia (MESH:C567355)
- **Chemicals:** azithromycin (MESH:D017963), methylprednisolone (MESH:D008775), folic acid (MESH:D005492)
- **Species:** Homo sapiens (human, species) [taxon 9606], Adenoviridae (family) [taxon 10508]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13020115/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC13020115/full.md

---
Source: https://tomesphere.com/paper/PMC13020115